SG Americas Securities’s Agilon Health AGL Stock Holding History

SG Americas Securities’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101K	Buy	+941	New	+$61.6K	﹤0.01%	3113
2026 Q1	–	Sell	-10,690	Closed	-$184K	–	3183
2025 Q4	$184K	Sell	10,690 -1,047	-9%	-$20.3K	﹤0.01%	2964
2025 Q3	$302K	Buy	11,737 +2,501	+27%	+$94.5K	﹤0.01%	2478
2025 Q2	$531K	Buy	9,236 +3,468	+60%	+$278K	﹤0.01%	1637
2025 Q1	$624K	Buy	5,768 +5,347	+1,270%	+$465K	﹤0.01%	1590
2024 Q4	$20K	Sell	421 -516	-55%	-$31.2K	﹤0.01%	3009
2024 Q3	$92K	Buy	+937	New	+$121K	﹤0.01%	3102
2024 Q1	–	Sell	-1,964	Closed	-$616K	–	2936
2023 Q4	$616K	Buy	1,964 +1,449	+281%	+$524K	0.01%	1336
2023 Q3	$229K	Buy	515 +255	+98%	+$115K	﹤0.01%	2233
2023 Q2	$113K	Buy	260 +74	+40%	+$41.6K	﹤0.01%	2048
2023 Q1	$110K	Buy	+186	New	+$104K	﹤0.01%	2845
2022 Q3	–	Sell	-317	Closed	-$173K	–	3158
2022 Q2	$173K	Buy	+317	New	+$160K	﹤0.01%	2772

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SG Americas Securities's AGL Position: Q2 2026 in Review

SG Americas Securities opened a new position in Agilon Health (AGL) in Q2 2026: 941 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #3113 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in AGL as recently as Q4 2025.

SG Americas Securities first reported a position in AGL in Q2 2022 and has held it in 12 quarters since. The position peaked at $624K in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

SG Americas Securities held 941 shares of Agilon Health worth $101K as of Q2 2026.
Agilon Health was a new SG Americas Securities position in Q2 2026.
Agilon Health made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3113 holding.
SG Americas Securities first reported a position in Agilon Health in Q2 2022 and has held it in 12 quarters since.
SG Americas Securities's Agilon Health position peaked at $624K in Q1 2025.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.